231 related articles for article (PubMed ID: 34494385)
1. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation.
Wen S; Deng F; Li L; Xu L; Li X; Fan Q
J Diabetes Investig; 2022 Jan; 13(1):22-33. PubMed ID: 34494385
[TBL] [Abstract][Full Text] [Related]
2. Alpha-kinase1 promotes tubular injury and interstitial inflammation in diabetic nephropathy by canonical pyroptosis pathway.
Cui X; Li Y; Yuan S; Huang Y; Chen X; Han Y; Liu Z; Li Z; Xiao Y; Wang Y; Sun L; Liu H; Zhu X
Biol Res; 2023 Feb; 56(1):5. PubMed ID: 36732854
[TBL] [Abstract][Full Text] [Related]
3. VX-765 ameliorates inflammation and extracellular matrix accumulation by inhibiting the NOX1/ROS/NF-κB pathway in diabetic nephropathy.
Wang X; Wu T; Ma H; Huang X; Huang K; Ye C; Zhu S
J Pharm Pharmacol; 2022 Mar; 74(3):377-386. PubMed ID: 34383065
[TBL] [Abstract][Full Text] [Related]
4. Gasdermin D is involved in switching from apoptosis to pyroptosis in TLR4-mediated renal tubular epithelial cells injury in diabetic kidney disease.
Yuan S; Wang Y; Li Z; Chen X; Song P; Chen A; Qu Z; Wen S; Liu H; Zhu X
Arch Biochem Biophys; 2022 Sep; 727():109347. PubMed ID: 35809639
[TBL] [Abstract][Full Text] [Related]
5. Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis.
McKenzie BA; Mamik MK; Saito LB; Boghozian R; Monaco MC; Major EO; Lu JQ; Branton WG; Power C
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6065-E6074. PubMed ID: 29895691
[TBL] [Abstract][Full Text] [Related]
6. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
Qu X; Zhai B; Liu Y; Chen Y; Xie Z; Wang Q; Wu Y; Liu Z; Chen J; Mei S; Wu J; You Z; Yu Y; Wang Y
Biomed Pharmacother; 2022 Jun; 150():112998. PubMed ID: 35489281
[TBL] [Abstract][Full Text] [Related]
7. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
[TBL] [Abstract][Full Text] [Related]
8. Carnosine alleviates podocyte injury in diabetic nephropathy by targeting caspase-1-mediated pyroptosis.
Zhu W; Li YY; Zeng HX; Liu XQ; Sun YT; Jiang L; Xia LL; Wu YG
Int Immunopharmacol; 2021 Dec; 101(Pt B):108236. PubMed ID: 34653727
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant Effect of Paeoniflorin Is Through Inhibiting Pyroptosis CASP-11/GSDMD Pathway.
Tian DD; Wang M; Liu A; Gao MR; Qiu C; Yu W; Wang WJ; Zhang K; Yang L; Jia YY; Yang CB; Wu YM
Mol Neurobiol; 2021 Feb; 58(2):761-776. PubMed ID: 33025508
[TBL] [Abstract][Full Text] [Related]
10. The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway.
Do Carmo H; Arjun S; Petrucci O; Yellon DM; Davidson SM
Cardiovasc Drugs Ther; 2018 Apr; 32(2):165-168. PubMed ID: 29582211
[TBL] [Abstract][Full Text] [Related]
11. Wogonin Alleviates Kidney Tubular Epithelial Injury in Diabetic Nephropathy by Inhibiting PI3K/Akt/NF-κB Signaling Pathways.
Lei L; Zhao J; Liu XQ; Chen J; Qi XM; Xia LL; Wu YG
Drug Des Devel Ther; 2021; 15():3131-3150. PubMed ID: 34295152
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-antisense non-coding RNA in the INK4 locus promotes pyroptosis via miR-497/thioredoxin-interacting protein axis in diabetic nephropathy.
Wang J; Zhao SM
Life Sci; 2021 Jan; 264():118728. PubMed ID: 33160992
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway.
Zhang S; Wang H; Liu Y; Yang W; Liu J; Han Y; Liu Y; Liu F; Sun L; Xiao L
J Cell Mol Med; 2020 Sep; 24(17):9810-9824. PubMed ID: 32779844
[TBL] [Abstract][Full Text] [Related]
14. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis.
Jia J; Tan R; Xu L; Wang H; Li J; Su H; Zhong X; Liu P; Wang L
Int Immunopharmacol; 2024 Jun; 135():112303. PubMed ID: 38776855
[TBL] [Abstract][Full Text] [Related]
15. GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy.
Zuo Y; Chen L; Gu H; He X; Ye Z; Wang Z; Shao Q; Xue C
Expert Rev Mol Med; 2021 Dec; 23():e23. PubMed ID: 34955116
[TBL] [Abstract][Full Text] [Related]
16. Caspase-1 inhibitor exerts brain-protective effects against sepsis-associated encephalopathy and cognitive impairments in a mouse model of sepsis.
Xu XE; Liu L; Wang YC; Wang CT; Zheng Q; Liu QX; Li ZF; Bai XJ; Liu XH
Brain Behav Immun; 2019 Aug; 80():859-870. PubMed ID: 31145977
[TBL] [Abstract][Full Text] [Related]
17. Hirudin ameliorates diabetic nephropathy by inhibiting Gsdmd-mediated pyroptosis.
Han J; Zuo Z; Shi X; Zhang Y; Peng Z; Xing Y; Pang X
Cell Biol Toxicol; 2023 Jun; 39(3):573-589. PubMed ID: 34212273
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of GSDMD mediated glomerular endothelial cells pyroptosis: An implying in the progression of diabetic nephropathy.
Shao Y; Deng S; Tang W; Huang L; Xie Y; Yuan S; Tang L
Int Immunopharmacol; 2023 Sep; 122():110632. PubMed ID: 37451013
[TBL] [Abstract][Full Text] [Related]
19. [Screening potential Chinese materia medica and their monomers for treatment diabetic nephropathy based on caspase-1-mediated pyroptosis].
Zhao W; He C; Wang F
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Sep; 40(9):1280-1287. PubMed ID: 32990240
[TBL] [Abstract][Full Text] [Related]
20. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
